Home > Healthcare > Medical Devices > Medical Supplies > anesthesia co2 absorbents market
Get a free sample of Anesthesia CO2 Absorbents Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Anesthesia CO2 Absorbents Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
The global market is primarily driven by growing burden of chronic diseases globally. Chronic diseases often require surgical interventions for treatment or management. With a growing population of individuals suffering from chronic conditions such as heart disease, cancer, diabetes, and respiratory disorders, the number of surgical procedures, both elective and non-elective, will increase thereby directly contributing to the demand for anesthesia services and CO2 absorbents.
Some of the major anesthesia CO2 absorbents companies are 3M, Baxter International, GE Healthcare, Cardinal Health, Beijing Kingst Commercial & Trade Co., Ltd., Ecolab Inc., Medline Industries, Inc., Philips Healthcare, Teleflex Incorporated, and Thermo Fisher Scientific.
U.S. anesthesia CO2 absorbents industry generated USD 20.9 million in revenue in 2022 and is estimated to expand at notable CAGR from 2023-2032 owing to higher technological advancements coupled with substantial healthcare expenditure in the region.
Anesthesia CO2 absorbents industry size from the medisorb segment generated USD 23.3 million in 2022 and is set to witness high demand through 2032 owing to rising application in surgeries to offer prolonged use capacity and cost-effectiveness.
Anesthesia CO2 absorbents industry was worth USD 74.1 million in revenue in 2022 and is projected to reach USD 121.9 million by 2032 driven by increasing usage in the surging number of surgical procedures globally.